Compare AbCellera Biologics Inc (ABCL) vs Jabil Inc (JBL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AbCellera Biologics Inc vs Jabil Inc — how do they compare? AbCellera Biologics Inc trades at $9.18 (market cap $2.99B), while Jabil Inc trades at $362.37 (market cap $37.37B). The key difference: Jabil Inc is far larger — about 12.5× AbCellera Biologics Inc's market cap, and Jabil Inc pays a 0.09% dividend while AbCellera Biologics Inc pays none. Which is the better fit depends on your goals.
| ABCL | JBL | |
|---|---|---|
Market Cap | $2.99B | $37.37B |
Sector | Health | Technology |
52-Week High | $9.76 | $385.50 |
52-Week Low | $2.78 | $192.49 |
Enterprise Value | $2.58B | $39.90B |
Dividend Yield | — | 0.09% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About Jabil Inc
Jabil is a global manufacturing solutions provider for industries including healthcare, automotive, and cloud. It offers comprehensive design, engineering, and supply chain management for complex electronic products.
Read more on JBL →
